Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

House Bill Banning “Reverse Settlements” Would Give FTC Exemption Power

Executive Summary

A bill introduced by Rep. Bobby Rush, D-Ill., banning "reverse" settlements between brand and generic companies would give the Federal Trade Commission the power to allow any such agreement it deems furthers market competition

You may also be interested in...



Brand/Generic Settlements Return To Capitol Hill

Apotex could make its case for scrapping first-to-file exclusivity during a hearing in Rep. Rush’s subcommittee.

FTC May Set Parameters Of Acceptable Brand/Generic Reverse Settlements

While the Federal Trade Commission is continuing its battle against reverse settlements, the agency concedes that not all deals are anticompetitive - and it would like to delineate which ones are acceptable

FTC May Set Parameters Of Acceptable Brand/Generic Reverse Settlements

While the Federal Trade Commission is continuing its battle against reverse settlements, the agency concedes that not all deals are anticompetitive - and it would like to delineate which ones are acceptable

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS048331

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel